Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis

被引:6
|
作者
Nita, Eleni [1 ]
Bairaktari, Eleni [2 ]
Kolios, George [2 ]
Migkos, Michail P. [3 ]
Somarakis, Georgios-Petros [3 ]
Markatseli, Theodora [3 ]
Archimandriti, Dimitra [3 ]
Tsaousi, Christina [4 ]
Voulgari, Paraskevi V. [3 ]
机构
[1] Univ Hosp Ioannina, Microbiol Lab, Ioannina, Greece
[2] Univ Ioannina, Med Sch, Lab Clin Chem, Ioannina, Greece
[3] Univ Ioannina, Med Sch, Dept Internal Med, Rheumatol Clin, Ioannina, Greece
[4] Univ Hosp Ioannina, Hematol Lab, Ioannina, Greece
关键词
principal component analysis; iron; functional iron deficiency; dimension reduction; CELL DISTRIBUTION WIDTH; IRON-BINDING-CAPACITY; SERUM HEPCIDIN; TRANSFERRIN CONCENTRATION; RADIOGRAPHIC PROGRESSION; INFLAMMATION; HEMOGLOBIN; DEFICIENCY; FERROPORTIN; METABOLISM;
D O I
10.1055/s-0041-1732827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Anemia of chronic disease is a frequent consequence in rheumatoid arthritis and is associated with major clinical and patient outcomes. The present cross-sectional study explored the role of hepcidin (HEP) in anemia of chronic disease in rheumatoid arthritis by studying its relationships with markers of anemia, iron metabolism, inflammation, and erythropoiesis. Methods: Blood samples from anemic (n = 43) and nonanemic (n = 43) rheumatoid arthritis patients were analyzed for markers of anemia (hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red cells distribution width, and reticulocyte hemoglobin), iron metabolism (iron, total iron binding capacity, ferritin, transferrin saturation, soluble transferrin receptor), inflammation (erythrocyte sedimentation rate, C-reactive protein, and interleukin 6), and erythropoiesis (erythropoietin and HEP). Correlation analysis was used to identify relationships between HEP and all other variables. Principal component analysis was used to identify common underlying dimensions representing linear combinations of all variables. Results: HEP had statistically significant mostly moderate-to-large correlations with markers of anemia (0.30-0.70, all p < 0.01), small correlation with markers of iron metabolism and markers of inflammation (r = 0.20-0.40, all p < 0.01), and moderate correlations with markers of erythropoiesis. Principal component analysis revealed two underlying components (factors) capturing approximately 50% of total variability. Factor 1 comprised mainly of markers of anemia, iron metabolism, and erythropoiesis and was related to "erythrocyte health status," while factor 2 comprised mainly markers of inflammation and iron metabolism and was related to "acute phase reactants." HEP was the only variable demonstrating substantial loadings on both factors. Conclusions: HEP is related to markers of anemia, iron metabolism, inflammation, and erythropoiesis. In addition, when all variables are "reduced" to a minimum number of two "latent" factors, HEP is loaded on both, thus underlying its pivotal role in the complex interaction of the erythropoietic response in inflammation-induced anemia and/or functional iron deficiency.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 50 条
  • [1] Does hepcidin take role on anemia in rheumatoid arthritis?
    Isik, A.
    Koca, S.
    Metin, K.
    Ustundag, B.
    Dag, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 357 - 358
  • [2] Role of cytokines in the pathogenesis of anemia of chronic disease in rheumatoid arthritis
    Voulgari, PV
    Kolios, G
    Papadopoulos, GK
    Katsaraki, A
    Seferiadis, K
    Drosos, AA
    [J]. CLINICAL IMMUNOLOGY, 1999, 92 (02) : 153 - 160
  • [3] THE ROLE OF ERYTHROPOIETIN IN THE ANEMIA OF CHRONIC DISEASE IN RHEUMATOID-ARTHRITIS
    VREUGDENHIL, G
    SWAAK, AJG
    [J]. CLINICAL RHEUMATOLOGY, 1990, 9 (01) : 22 - 27
  • [4] The effectiveness of etanercept and adalimumab on anemia of chronic disease and serum hepcidin in patients with rheumatoid arthritis, a comparative study
    Abu-Zaid, M. H.
    El Morsya, S.
    Rageh, E. M.
    Shahba, A.
    Gaber, R. A.
    [J]. EGYPTIAN RHEUMATOLOGIST, 2018, 40 (04): : 233 - 237
  • [5] Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin
    Khalaf, Warqaa
    Al-Rubaie, Haithem Ahmed
    Shihab, Sami
    [J]. HEMATOLOGY REPORTS, 2019, 11 (01) : 16 - 19
  • [6] ROLE OF HEPCIDIN IN MECHANISM OF ANEMIA CHRONIC DISEASE PATIENTS
    Suega, Ketut
    [J]. BALI MEDICAL JOURNAL, 2014, 3 (02) : 89 - 96
  • [7] Hepcidin and the anemia of chronic disease
    Haurani, FI
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2006, 36 (01): : 3 - 6
  • [8] Hepcidin in chronic kidney disease anemia
    Santos-Silva, Alice
    Ribeiro, Sandra
    Reis, Flavio
    Belo, Luis
    [J]. IRON METABOLISM: HEPCIDIN, 2019, 110 : 243 - 264
  • [9] Circulating Hepcidin in the Crossroads of Anemia and Inflammation Associated with Rheumatoid Arthritis
    Demirag, Mehmet Derya
    Haznedaroglu, Seminur
    Sancak, Banu
    Konca, Ceyla
    Gulbahar, Ozlem
    Ozturk, M. Akif
    Goker, Berna
    [J]. INTERNAL MEDICINE, 2009, 48 (06) : 421 - 426
  • [10] Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond
    Ueda, Norishi
    Takasawa, Kazuya
    [J]. CURRENT MEDICINAL CHEMISTRY, 2017, 24 (14) : 1417 - 1452